Promising TNF-α inhibitors: Targeting pathogenic TNF-α/TNFR signaling to restore Th17/Treg balance in rheumatoid arthritis
Journal of Pharmaceutical Analysis · 2026-03 · 16 (3) · 101382
DOI: 10.1016/j.jpha.2025.101382 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Pharmaceutical Analysis, 2026-03. Verfasst von Jiajie Kuai und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Pharmacology, Anhui Medical University, Key Laboratory of Anti-Inflammatory and Immune Medicine (Anhui Medical University), Min…. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 139 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
The pleiotropic regulatory effect of tumor necrosis factor-alpha (TNF-α), an essential cytokine involved in immune regulation, is of significant importance in the immune response. TNF-α inhibitors have been widely used in rheumatoid arthritis (RA) and other autoimmune diseases since their introduction into clinical practice. However, the tradeoff between its excellent efficacy and adverse drug reactions (ADR) remains a problem. T cells, especially the T helper cell 17 (Th17)/regulatory T (Treg) cells balance, are crucial for the treatment of autoimmune diseases including RA. This review explores the mechanisms by which TNF-α/TNF receptor (TNFR) signaling induces Th17/Treg imbalance in RA. This review synthesizes current knowledge to facilitate an improved understanding of the causes of ADR, such as infection caused by TNF-α inhibitors in clinical practice. Moreover, our findings offer a reference for exploring potential TNF-α/TNFR signaling inhibitory strategies from the perspective of regulating T cell balance.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Clinical Pharmacology, Anhui Medical University, Key Laboratory of Anti-Inflammatory and Immune Medicine (Anhui Medical University), Ministry of Education, Anhui Collaborative Innovation Center of Anti-infl…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Kuai, J., Chen, Z., He, J., Wang, F., & Wei, W. (2026). Promising TNF-α inhibitors: Targeting pathogenic TNF-α/TNFR signaling to restore Th17/Treg balance in rheumatoid arthritis. Journal of Pharmaceutical Analysis, 16(3), 101382. https://doi.org/10.1016/j.jpha.2025.101382
Vancouver
Kuai J, Chen Z, He J, Wang F, Wei W. Promising TNF-α inhibitors: Targeting pathogenic TNF-α/TNFR signaling to restore Th17/Treg balance in rheumatoid arthritis. Journal of Pharmaceutical Analysis. 2026;16(3):101382. doi:10.1016/j.jpha.2025.101382
BibTeX
@article{Kuai2026,
author = {Kuai, Jiajie and Chen, Zhuo and He, Ju and Wang, Fengling and Wei, Wei},
title = {Promising TNF-α inhibitors: Targeting pathogenic TNF-α/TNFR signaling to restore Th17/Treg balance in rheumatoid arthritis},
journal = {Journal of Pharmaceutical Analysis},
year = {2026},
volume = {16},
number = {3},
pages = {101382},
doi = {10.1016/j.jpha.2025.101382}
}
EUVIMED